George Sekulich

Fortune : 35 $ au 31/05/2024

59 ans

Health Technology

Consumer Services

Postes actifs de George Sekulich

Sociétés	Poste	Début	Fin
EMMAUS LIFE SCIENCES, INC.	Directeur/Membre du Conseil	02/10/2023	-
	President	23/08/2023	-
	Directeur Technique/Scientifique/R&D	01/05/2019	23/08/2023
EMI Holding, Inc. EMI Holding, Inc. Pharmaceuticals: MajorHealth Technology EMI Holding, Inc. discovers, develops, and commercializes treatments and therapies for rare diseases. The firm also engages in the marketing and sale of NutreStore L-glutamine powder for oral solution, a treatment for short bowel syndrome and the sale of L-glutamine as a nutritional supplement under the brand name AminoPure. The company was founded by Yutaka Niihara in 1987 and is headquartered in Torrance, CA.	Directeur Technique/Scientifique/R&D	01/09/2014	-

Sociétés	Poste	Début	Fin
Magellan Network Systems, Inc.	Corporate Officer/Principal	-	-

California State University-Dominguez Hills

Undergraduate Degree

Internationale

Etats-Unis

Opérationnelle

Sectorielle

Health Technology	3
Consumer Services	2

Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Sociétés cotées	1
EMMAUS LIFE SCIENCES, INC.	Health Technology

Entreprise privées	2
Magellan Network Systems, Inc.
EMI Holding, Inc. EMI Holding, Inc. Pharmaceuticals: MajorHealth Technology EMI Holding, Inc. discovers, develops, and commercializes treatments and therapies for rare diseases. The firm also engages in the marketing and sale of NutreStore L-glutamine powder for oral solution, a treatment for short bowel syndrome and the sale of L-glutamine as a nutritional supplement under the brand name AminoPure. The company was founded by Yutaka Niihara in 1987 and is headquartered in Torrance, CA.	Health Technology

Entreprise privées

Magellan Network Systems, Inc.

Health Technology